Guidelines for the diagnosis and treatment of acute non-variceal upper gastrointestinal bleeding;Recomendaciones para el diagnóstico y el tratamiento de la hemorragia digestiva alta aguda no varicosa

Gastroenterologia y Hepatologia

Volumn 26, Issue 2, 2003, Pages 70-85

  Feu, F ^a,d   Brullet, E ^b   Calveta, X ^a   Fernandez Llamazares J ^c   Guardiola, J ^a   Moreno, P ^c   Panades A ^b   Salo J ^a   Saperas, E ^a   Villanueva, C ^a   Planas, R ^a  

^a Societat Catalana de Cirurgia   (Spain)

^b Soc Catalana d'Endoscopia Digestiva   (Spain)

^c Societat Catalana de Cir Digestiva ^*  (Spain)

^d HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CIMETIDINE; ESOMEPRAZOLE; FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; NIZATIDINE; OCTREOTIDE; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; RABEPRAZOLE; RANITIDINE; SOMATOSTATIN; SOMATOSTATIN DERIVATIVE;

ANAMNESIS; ARTICLE; BLOOD TRANSFUSION; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; ELECTROCOAGULATION; ENDOSCOPIC THERAPY; ENDOSCOPY; ESOPHAGITIS; HEMOSTASIS; HUMAN; INCIDENCE; LASER COAGULATION; MALLORY WEISS SYNDROME; MEDICAL EXAMINATION; MORTALITY; PRACTICE GUIDELINE; PROGNOSIS; SCAR FORMATION; THERMOCOAGULATION; TREATMENT INDICATION; UPPER GASTROINTESTINAL BLEEDING;

EID: 12244313432     PISSN: 02105705     EISSN: None     Source Type: Journal    
DOI: 10.1157/13042813     Document Type: Article

References (147)

1. Laine L, Peterson WL. Bleeding peptic ulcer. N Engl J Med 1994;331:717-27.
2. Branicki FJ, Coleman SY, Fok PJ, Pritchett CJ, Fan ST, Lai EC, et al. Bleeding peptic ulcer: a prospective evaluation of risk factors for rebleeding and mortality. World J Surg 1990;14:262-9.
3. Vreeburg EM, Terwee CB, Snel P, Rauws EAJ, Bartelsman JFWM, Meulen JHP, et al. Validation of the Rockall risk scoring system in upper gastrointestinal bleeding. Gut 1999;44:331-5.
4. Llach J, Bordas JM, Salmerón JM, Panés J, García Pagán JC, Feu F, et al. A prospective randomized trial of heater probe thermocoagulation versus injection therapy in peptic ulcer hemorrhage. Gastrointest Endosc 1996;43:117-20.
5. Bornman PC, Theodorou NA, Suttleworth RD, Essel HP, Marks IN. Importance of hypovoloamic shock and endoscopic signs in predicting recurrent haemorrhage from peptic ulceration: a prospective evaluation. BMJ 1985;291:245-7.
6. Bordley DR, Mushlin AI, Dolan JG, Richardson WS, Barry M, Polio J, et al. Early clinical signs identify low-risk patients with acute upper gastrointestinal hemorrhage. JAMA 1985;253:3282-5.
7. De Dombal FT, Clarke JR, Clamp SE, Malicia G, Kotwal MR, Morgan AG. Prognostic factors in upper GI bleeding. Endoscopy 1986;18(Suppl 2):6-10.
8. Rockall TA, Logan RFA, Devlin HB, Northfield TC. Risk assessment after acute upper gastrointestinal haemorrhage. Gut 1996;38:316-21.
9. Rockall TA, Logan RFA, Devlin HB, Northfield TC, for the National Audit of Acute Upper Gastrointestinal Haemorrhage. Selection of patients for early discharge or outpatient care after acute upper gastrointestinal haemorrhage. Lancet 1996;347:1138-40.
10. Cook DJ, Guyatt GH, Salena BJ, Laine LA. Endoscopic therapy for acute nonvariceal upper gastrointestinal hemorrhage: a meta-analysis. Gastroenterology 1992;102:139-48.
11. Pardo A, Durández R, Hernández M, Pizarro A, Hombrados M, Jiménez A, et al. Impact of physician specialty on the cost of nonvariceal upper GI bleeding care. Am J Gastroenterol 2002;97:1535-42.
12. Bickell WH, Wall MJ, Pepe PE, Martin RR, Ginger VF, Allen MK, et al. Immediate versus delayed resuscitation for hypotensive patients with penetrating torso injuries. N Engl J Med 1994;331:1165-9.
13. Herbert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, et al. A multicenter, randomizedcontrolled clinical trial on transfusion requirements in critical care. N Engl J Med 1999;340:409-17.
14. Bickell WH, Bruttig SP, Millnamow GA, O'Benar J, Wade CE. The detrimental effects of intravenous crystalloid after aortotomy in swine. Surgery 1991;110:529-36.
15. Stern SA Dronen, SC, Birrer P, Wang X. Effect of blood pressure on haemorrhage volume and survival in a near-fatal hemorrhage model incorporating a vascular injury. Ann Emerg Med 1993;22:1155-63.
16. Duggan JM. Haematemesis patients should be managed in special units. Med J Aust 1986:44:247-50.
17. Rofe SB, Duggan JM, Smith ER, Thrusby CJ. Conservative treatment of gastrointestinal haemorrhage. Gut 1981;26:481-4.
18. Blair SD, Janvrin SB, McCollum CN, Greenhalgh RM. Effect of early blood! transfusion on gastrointestinal haemorrhage. Br J Surg 1986;7:783-5.
19. Dawson RB. Preservation of red cells for transfusión. Hum Pathol 1983;14:213-7.
20. Houbiers JGA, Brand A, Van de Watering LMG, Hermans J, Verwey PJ. Bijnen AB, et al. Randomised controlled trial comparing transfusion of leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer. Lancet 1994:344:573-7.
21. Elizalde JI, Clemente J, Marin JL, Panes J, Aragon B, Mas A, et al. Early changes in hemoglobin and hematocrit levels after packed red cell transfusion in patients with acute anemia. Transfusion 1997;37:573-6.
22. Laine L, Cohen H, Bordead J, Cantor D, Garcia F, Mosquera M. Prospective evaluation of immediate versus delayed re-feeding and prognostic value of endoscopy in patients with upper gastrointestinal hemorrhage. Gastroenterology 1992;102:314-6.
23. De Ledinghen V, Beau P, Mannant PR, Ripault MP, Borderie C, Silvain C, et al. When should patients with bleeding peptic ulcer resume oral intake? A randomized controlled study. Gastroenterol Clin Biol 1998;22:282-5.
24. Chak A, Cooper GS, Lloyd LE, Kolz CS, Barnhart BA, Wong RCK. Effectiveness of endoscopy in patients admitted to the intensive care unit with upper GI hemorrhage. Gastrointest Endosc 2001;53:6-13.
25. Hsu P, Lai K, Lin X, Yang YF, Lin M, Shin JS, et al. When to discharge patients with bleeding, peptic ulcers: a prospective study of residual risk of bleeding. Gastrointest Endosc 1996;44:382-7.
26. Campo R, Brullet E, Calvet X, et al. Safety of outpatient management of nonvariceal upper gastrointestinal bleeding: preliminary results of a randomized study. Gastrointest Endosc 1998;47:AB81.
27. Lai K, Hui W, Wong B, Cing C, Lam S. A retrospective and prospective study on the safety of discharging selected patients with duodenal ulcer bleeding on the same day as endoscopy. Gastrointest Endosc 1998;45:26-30.
28. Longstreth GF, Feitelberg SP. Successful outpatient management of acute upper gastrointestinal hemorrhage: use of practice guidelines in a large patient series. Gastrointest Endosc 1998;47:219-21.
29. Lee JG, Turnipseed S, Romano PS, Vigil H, Azari R, Melnikoff N, et al. Endoscopy-based triage significantly reduces hospitalization rates and costs of treating upper GI bleeding: a randomized controlled trial. Gastrointest Endosc 1999;50:755-61.
30. Lin HJ, Wang K, Perng CL, Chua RT, Lee FY, Lee CH, et al. Early or delayed endoscopy for patients with peptic ulcer bleeding: a prospective randomized study. J Clin Gastroenterol 1996;22:267-71.
31. Cooper GS, Chak A, Connors AF, Harper DL, Rosenthal GE. The effectiveness of early endoscopy for upper gastrointestinal hemorrhage. Med Care 1998;36:462-74.
32. Cooper GS, Chak A, Way L, Hammar P, Harper D, Rosenthal G. Early endoscopy in upper gastrointestinal hemorrhage: associations with recurrent bleeding, surgery, and length of hospital stay. Gastrointest Endosc 1999;49:145-52.
33. Hay JA, Maldonado L, Weingarten SR, Ellrodt GA. Prospective evaluation of a clinical guideline recommending hospital length of stay in upper gastrointestinal tract hemorrhage. JAMA 1997;278:2152-6.
34. Panés J, Viver J, Forné M, García-Olivares E, Marco C, Garau J. Controlled trial of endoscopic sclerosis in bleeding peptic ulcers. Lancet 1987;2:1292-4.
35. Jensen DM, Kovacs TOG, Jutabha R, Machicado GA, Gralnek IM, Savides TJ, et al. Randomized trial of medical or endoscopic therapy to prevent recurrent ulcer hemorrhage in patients with adherent clots. Gastroenterology 2002;123:407-13.
36. Bleau BL, Gostout CJ, Sherman KE, Shaw MJ, Harford WV, Keate RF, et al. Recurrent bleeding from peptic ulcer associated with adherent clot: a randomized study comparing endoscopic treatment with medical therapy. Gastrointest Endosc 2002;56:1-6.
37. Palmer KR, Choudari CP. Endoscopic intervention in bleeding peptic ulcer. Gut 1995;37:161-4.
38. Villanueva C, Balanzó J, Torras X, Soriano G, Sainz S, Vilardell F. Value of second-look endoscopy after injection therapy for bleeding peptic ulcer: a prospective and randomized trial. Gastrointest Endosc 1994;40:34-9.
39. Elizalde JI, Llach J, Bordas JM, Bataller R, Mondelo F, Panés J, et al. Valor del control endoscópico tras la escleroterapia por lesión péptica gastroduodenal. Gastroenterol Hepatol 1994;17:11-3.
40. Saeed ZA, Winchester CB, Michaletz PA, Woods KL, Graham DY. A scoring system to predict rebleeding after endoscopic therapy of nonvariceal upper gastrointestinal hemorrhage, with a comparison of heat probe and ethanol injection. Am J Gastroenterol 1993;88:1842-9.
41. Hay JA, Lyubashevsky E, Elashoff J, Maldonado L, Weingarten SR, Ellrodt GA. Upper gastrointestinal hemorrhage clinical guideline - Determining the optimal hospital length of stay. Am J Med 1996;100:313-22.
42. Villanueva C, Balanzó J, Espinós JC, Domènech JM, Sáinz S, Call J, et al. Prediction of therapeutic failure in patients with bleeding peptic ulcer treated with endoscopic injection. Dig Dis Sci 1993;38:2062-70.
43. Saeed ZA, Ramírez FC, Hepps KS, Cole RA, Graham DY. Prospective validation of the Baylor bleeding score for predicting the likelihood of rebleeding after endoscopic hemostasis of peptic ulcers. Gastrointest Endosc 1995;41:561-5.
44. Park KG, Steele RJ, Mollison J, Crofts TJ. Prediction of recurrent bleeding after endoscopic haemostasis in non-variceal upper gastrointestinal haemorrhage. Br J Surg 1994;81:1465-8.
45. Brullet E, Calvet X, Campo R, Rue M, Catot L, Donoso L. Factors oredicting failure of endoscopic injection therapy in bleeding duodenal ulcer. Gastrointest Endosc 1996;43:111-6.
46. Brullet E, Campo R, Calvet X, Coroleu D, Rivero E, Simo Deu J. Factors related to the failure of endoscopic injection therapy for bleeding gastric ulcer. Gut 1996;39:155-8.
47. Wong SK, Yu LM, Lau JY, Lam YH, Chan AC, Ng EK, et al. Prediction of therapeutic failure after adrenaline injection plus heater probe treatment in patients with bleeding peptic ulcer. Gut 2002;50:322-5.
48. Moreno P, Jaurrieta E, Aranda H, Fabregat J, Farran L, Biondo S, et al. Efficacy and safety of an early discharge protocol in low-risk patients with upper gastrointestinal bleeding. Am J Med 1998;105:176-81.
49. Blatchford O, Murray WR, Blatchford M. A risk score to predict need for treatment for upper-gastrointestinal haemorrhage. Lancet 2000;356:1318-21.
50. Phang TS, Vomik V, Stubbs R. Risk assessment in upper gastrointestinal haemorrhage: implications for resource utilisation. N Z Med J 2000;113:33-333.
51. Church NI, Palmer KR. Relevance of the Rockall score in patients undergoing endoscopic therapy for peptic ulcer haemorrhage. Eur J Gastroenterol Hepatol 2001;13:1149-52.
52. Feu F, Mata A, Peñalva M, Blasco A, Piqué JM. Application of a clinical guideline for upper gastrointestinal bleeding using Rockall score shortens hospital stay without affecting mortality. Gastroenterology 2002;122:A477.
53. Longstreth GF, Feitelberg SB. Successful outpatient management of acute upper gastrointestinal hemorrhage: use of practice guidelines in a large patient series. Gastrointest Endosc 1998;47:219-22.
54. Cipolletta L, Bianco MA, Rotondano G, Marmo R, Piscopo R. Outpatient management for low-risk nonvariceal upper GI bleeding: a randomized controlled trial. Gastrointest Endosc 2002;55:1-5.
55. Laine L. Multipolar electrocoagulation in the treatment of peptic ulcers with nonbleeding visible vessels. Ann Intern Med 1989;110:510-4.
56. Lin HJ, Lee FY, Kang WM, Tsai YT, Lee SD, Lee CH. A controlled study of therapeutic endoscopy for peptic ulcer with non-bleeding visible vessel. Gastrointest Endosc 1990;36:241-6.
57. Jaramillo JL, Carmona C, Gálvez C, De la Mata M, Miño G. Efficacy of the heater probe in peptic ulcer with a non-bleeding visible vessel. A controlled, randomised study. Gut 1993;34:1502-6.
58. Rutgeerts P, Gevers AM, Hiele M, Broeckaert L, Vantrappen G. Endoscopic injection therapy to prevent rebleeding from peptic ulcers with a protruding vessel: a controlled comparative trial. Gut 1993;34:348-50.
59. Parra-Blanco A, Takahashi H, Méndez Jerez PV, Kojima T, Aksoz K, Kirihara K, et al. Endoscopic mangement of Dieulafoy lesions of the stomach: a case study of 26 patients. Endoscopy 1997;29:834-9.
60. Chung IK, Kim EJ, Lee MS, Kim HS, Park SH, Lee MH, et al. Bleeding Dieulafoy's lesions and the choice of endoscopic method: comparing the hemostatic efficacy of mechanical and injection methods. Gastrointest Endosc 2000;52:721-4.
61. Kasapidis P, Georgopoulos P, Delis V, Balatsos V, Konstantinidis A, Skandalis N. Endoscopic management and long-term follow-up of Dieulafoy's lesions in the upper GI tract. Gastrointest Endosc 2002;55:527-31.
62. Llach J, Elizalde JI, Guevara MC, Pellise M, Castellot A, Gines A, et al. Endoscopic injection therapy in bleeding Mallory-Weiss syndrome: a randomized controlled trial. Gastrointest Endosc 2001;54:679-81.
63. Rutgeerts P, Rauws E, Wara P, Swain P, Hoos A, Solleder E, et al. Randomised trial of single and repeated fibrin glue compared with injection of polidocanol in treatment of bleeding peptic ulcer. Lancet 1997;350:692-6.
64. Balanzó J, Sainz S, Such J, Espinós JC, Guarner C, Cussó X, Monés J, Vilardell F. Endoscopic hemostasis by local injection of epinephrine and polidocanol in bleeding ulcer. A prospective randomized trial. Endoscopy 1988;20:289-91.
65. Chung SCS, Leung JWC, Steele RJC, Crofts TJ, Li AKC. Endoscopic injection of adrenaline for actively bleeding ulcers: a randomized trial. BMJ 1988;296:1631-3.
66. Oxner RBG, Simmonds NJ, Gertner DJ, Nightingale JMD, Burnham WR. Controlled trial of endoscopic injection treatment for bleeding from peptic ulcers with visible vessels. Lancet 1992;339:966-8.
67. Lin HJ, Perng CL, Lee SD. Is sclerosant injection mandatory after an epinephrine injection for arrest of peptic ulcer hemorrhage? A prospective, randomized, comparative study. Gut 1993;34:1182-5.
68. Kubba AK, Palmer KR. Role of endoscopic injection therapy in the treatment of bleeding ulcer. Br J Surg 1996;83:461-8.
69. Chung SC, Lau JL, Sung JJ. Randomised comparison between adrenaline injection alone and adrenaline injection plus heater probe treatment for actively bleeding peptic ulcers. BMJ 1997;314:1307-17.
70. Lin HJ, Hsieh YH, Tseng GY, Perng CL, Chang FY, Lee SD. A prospective, randomized trial of large- versus small-volume endoscopic injection of epinephrine for peptic ulcer bleeding. Gastrointest Endosc 2002;55:615-9.
71. Lin HJ, Lee FY, Kang WM, Tsai YT, Lee SD, Lee CH. Heat probe thermocoagulation and pure alcohol injection in massive peptic ulcer haemorrhage: a prospective, randomised controlled trial. Gut 1990;31:753-7.
72. Chung IK, Ham JS, Kim HS. Comparison of the hemostatic efficacy of the endoscopic hemoclip method with hypertonic saline-epinephrine injection and a combination of the two for the management of bleeding peptic ulcers. Gastrointest Endosc 1999;49:13-8.
73. Cipolletta L, Bianco MA, Marmo R, Rotondano G, Piscopo R, Vingiani AM, et al. Endoclips versus heater probe in preventing early recurrent bleeding from peptic ulcer: a prospective and randomized trial. Gastrointest Endosc 2001;53:147-51.
74. Abi-Hanna D, Williams SJ, Gillespie PA, Bourke MJ. Endoscopic band ligation for nonvariceal non ulcer gastrointestinal hemorrhage. Gastrointest Endosc 1998;48:510-4.
75. Wong RM, Ota S, Katoh A, Yamanchi A, Arai K, Yaneko K, et al. Endoscopic ligation for non-variceal esophageal upper gastrointestinal hemorrhage. Endoscopy 1998;30:774-7.
76. Rutgeerts P, Vantrappen G, Broeckaert L, Coremans G, Janssens J, Hiele M. Comparison of endoscopic polidocanol injection and YAG laser therapy for bleeding peptic ulcers. Lancet 1989;1:1164-7.
77. Krejs GJ, Little KH, Westergaard H, Hamilton JK, Spady DK, Polter DE. Laser photocoagulation for the treatment of acute peptic ulcer bleeding. N Engl J Med 1987;316:1618-21.
78. Swain CP, Kirkham JS, Salmon PR, Brown SG, Northfield TC. Controlled trial of Nd-YAG laser photocoagulation in bleeding peptic ulcers. Lancet 1986;2:1113-6.
79. Choudari CP, Rajgopal C, Elton RA, Palmer KR. Failures of endoscopic therapy for bleeding peptic ulcer: an analysis of risk factors. Am J Gastroenterol 1994;89:1968-72.
80. Green FW, Kaplan MM, Curtis LE, Levine PH. Effect of acid and pepsin on blood coagulation and platelet aggregation: a possible contributor to prolonged gastroduodenal mucosal hemorrhage. Gastroenterology 1978;74:38-43.
81. Patchett SE, Enright H, Afdhal N, O'Connell W, O'Donoghue DP. Clot lysis by gastric juice: an in vitro study. Gut 1989;30:1704-7.
82. Barkun AN, Cockeram AW, Plourde V, Fedorak RN. Review article: acid suppression in non-variceal acute upper gastrointestinal bleeding. Aliment Pharmacol Ther 1999;13:1565-84.
83. Merki HS, Wilder-Smith CH. Do continuous infusions of omeprazole and ranitidine retain their effect with prolonged dosing? Gastroenterology 1994;106:60-4.
84. Barer D, Ogilvie A, Henry D, Drontield M, Coggon D, French S, et al. Cimetidine and tranexamic acid in the treatment of acute upper gastrointestinal bleeding. N Engl J Med 1983;308:1571-5.
85. Collins R, Langman M. Treatment with histamine H, antagonist in acute upper gastrointestinal bleeding: implications of randomized trials. N Engl J Med 1985;313:660-6.
86. Walt RP, Cottrell J, Mann SG, Freemantle NP, Langman, MJ. Continuous intravenous famotidine for haemorrhage from peptic ulcer. Lancet 1992;340:1058-62.
87. Walt RP, Reynolds JR, Langman MJ, Smart HL, Kitchingman G, Somerville KW, et al. Intravenous omeprazole rapidly raises intragastric pH. Gut 1985;25:902-6.
88. Andersen J, Strom M, Naesdal J, Leire K, Walan A. Intravenous omeprazole: effect of a loading dose on 24-hour intragastric pH. Aliment Pharmacol Ther 1990;4:65-72.
89. Baak LC, Bièmond I, Jansen JB, Lamers CB. Repeated intravenous bolus injections of omeprazole: effects on 24-hour intragastric pH, serum gastrin, and serum pepsinogen A and C. Scand J Gastroenterol 1991;26:737-46.
90. Labenz J, Peitz U, Leusing C, Tillenburg B, Blum AL, Borsch G. Efficacy of primed infusions with high dose ranitidine and omeprazole to maintain high intragastric pH in patients with peptic ulcer bleeding: a prospective randomised controlled study. Gut 1997;40:36-41.
91. Hasselgren G, Keelan M, Kirdeikis P, Lee L, Rohss K, Sinclair P, et al. Optimization of acid suppression for patients with peptic ulcer bleeding: an intragastric pH-metry study with omeprazole. Eur J Gastroenterol Hepatol 1998;10:601-6.
92. Netzer P, Gaia C, Sandoz M, Huluk T, Gut A, Halter F, et al. Effect of repeated injection and continuous infusion of omeprazole and ranitidine on intragastric pH over 72 hours. Am J Gastroenterol 1999;94:351-7.
93. Brunner G, Luna P, Hartmann M, Wurst W. Optimizing the intragastric pH as a supportive therapy in upper GI bleeding. Yale J Biol Med 1996;69:225-31.
94. Daneshmend TK, Hawkey CJ, Langman MJS, Logan RF, Long RG, Walt RP. Omeprazole versus placebo for acute upper gastrointestinal bleeding: randomised double blind controlled trial. BMJ 1992;304:143-7.
95. Khuroo MS, Yattoo GN, Javid G, Khan BA, Shah AA, Gulzar GM, et al. A comparison of omeprazole and placebo for bleeding peptic ulcer. N Engl J Med 1997;336:1054-8.
96. Hasselgren G, Lind T, Lundell L, Aadland E, Efskind P, Falk A, et al. Continuous intravenous infusion of omeprazole in elderly patients with peptic ulcer bleeding. Results of a placebo-controlled multicenter study. Scand J Gastroenterol 1997;32:328-33.
97. Villanueva C, Balanzó J, Torras X, Sáinz S, Soriano G, González D, et al. Omeprazole versus ranitidine as adjuvant therapy to endoscopic injection in actively bleeding ulcers: a prospective and randomized study. Endoscopy 1995;27:308-12.
98. Schaffalitzky de Muckadell OB, Havelund T, Harling H, Boesby S, Snel P, Vreeburg EM, et al. Effect of omeprazole on the outcome of endoscopically treated bleeding peptic ulcers. Scand J Gastroenterol 1997;32:320-7.
99. Lin HJ, Lo WC, Lee FY, Perng CL, Tseng GY. A prospective randomized comparative trial showing that omeprazole prevents rebleeding in patients with bleeding peptic ulcer after successful endoscopic therapy. Arch Intern Med 1998;158:54-8.
100. Lau JY, Sung JJ, Lee KK, Yung MY, Wong SK, Wu JC et al. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. N Engl J Med 2000;343:319-6.
101. Zuckerman G, Welch R, Douglas A, Troxell R, Cohen S, Lorber S, et al. Controlled trial of medical therapy for active upper gastrointestinal bleeding and prevention of rebleeding. Am J Med 1984;76:361-7.
102. 2 antagonists and placebo in the management of acute non-variceal upper gastrointestinal hemorrhage: a metaanalysis. Ann Intern Med 1997;127:1062-71.
103. Kayasseh L, Gyr K, Keller U, Stalder GA, Wall M. Somatostatin and cimetidine in peptic-ulcer hemorrhage. Lancet 1980;1:844-6.
104. Basile M, Celi S, Parisi A, Castiglione N, Parisi S. Somatostatin in the treatment of severe gastrointestinal bleeding from peptic origin. A multicentric controlled trial. Ital J Surg Sci 1984;14:31-5.
105. Coraggio F, Scarpato P, Spina M, Lombardi S. Somatostatin and ranitidine in the control of iatrogenic haemorrhage of the upper gastrointestinal tract. BMJ 1984;289:224.
106. Antonioli A, Gandolfo M, Rigo GP, Bianchi Porro G, Cheli R, Brancato F, et al. Somatostatin and cimetidine in the control of acute upper gastrointestinal bleeding. A controlled multicenter study. Hepatogastroenterology 1986;33:71-4.
107. Torres AJ, Landa I, Hernandez F, Jover JM, Suárez A, Arias J, et al. Somatostatin in the treatment of severe upper gastrointestinal bleeding: a multicentre controlled trial. Br J Surg 1986;73:786-9.
108. Coraggio F, Bertini G, Catalano A, Scarpato P, Gualderi L. Clinical, controlled trial of somatostatin with ranitidine and placebo in the control of peptic hemorrhage of the upper gastrointestinal tract. Digestion 1989;43:190-5
109. Tulassay Z, Gupta R, Papp J, Bodnar A. Somatostatin versus cimetidine in the treatment of actively bleeding duodenal ulcer: a prospective, randomized, controlled trial. Am J Gastroenterol 1989;84:6-9.
110. Magnusson I, Ihre T, Johansson C, Seligson U, Törngren S, Uvnas-Moberg K. Randomised double blind trial of somatostatin in the treatment of massive upper gastrointestinal haemorrhage. Gut 1985;26:221-6.
111. Somerville KW, Henry DA, Davies JG, Hine KR, Hawkey CJ, Langman MJ. Somatostatin in treatment of haematemesis and melaena. Lancet 1985;1:130-2.
112. Basso N, Bagarani M, Bracci F, Cucchiara G, Gizzonio D, Grassini G, et al. Ranitidine and somatostatin. Their effects on bleeding from the upper gastrointestinal tract. Arch Surg 1986;121:833-5.
113. Saperas E, Piqué JM, Pérez-Ayuso R, Fuster F, Terés J, Bordas JM, et al. Somatostatin compared with cimetidine in the treatment of bleeding peptic ulcer without visible vessel. Aliment Pharmacol Ther 1988;2:153-9.
114. Lau JYW, Sung JJY, Lam YH, Chan ACW, Ng EKW, Lee DWH, Chan FKL, et al. Endoscopic retreatment compared with surgery in patients with recurrent bleeding after initial endoscopic control of bleeding ulcers. N Engl J Med 1999;340:751-6.
115. Monig SP, Lubke T, Baldus SE, Schafer H, Holscher AH. Early elective surgery for bleeding ulcer in the posterior duodenal bulb. Own results and review of the literature. Hepatogastroenterology 2002;49:416-8.
116. Walan A, Bader JP, Classen M, Lamers CBHW, Piper DW, Rutgersson K, et al. Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with bening gastric ulcer. N Engl J Med 1989;320:69-75.
117. Bardhan KD, Bianchi Porro G, Bose K, Daly M, Hinchliffe RF, Jonson E, et al. A comparison of two different doses of omeprazole versus ranitidine in treatment of duodenal ulcers. J Clin Gastroenterol 1986;8:408-13.
118. Bader JP, Delchier JC. Clinical efficacy of pantoprazole compared with ranitidine. Aliment Pharmacol Ther 1994;8(Suppl 1):47-52.
119. Kuipers EJ, Thijs JC, Festen HPM. The prevalence of Helicobacter pylori in peptic ulcer disease. Aliment Pharmacol Ther 1995;9(Suppl 2):59-69.
120. Gisbert JP, Boixeda D, Aller R, De la Serna C, Sanz E, Martín de Argila C, et al. Helicobacter pylori y hemorragia digestiva por úlcera duodenal: prevalencia de la infección, eficacia de tres terapias triples y papel de la erradicación en la prevención de la recidiva hemorrágica. Med Clin (Barc) 1999;112:161-5.
121. Ng TM, Fock KM, Khor JL, Teo EK, Sim CS, Tan AL, et al. Non-steroidal anti-inflammatory drugs, Helicobacter pylori and bleeding gastric ulcer. Aliment Pharmacol Ther 2000;14:203-9.
122. García-Altés A, Jovell AJ, Serra-Prat M, Aymerich M. Management of Helicobacter pylori in duodenal ulcer: a cost-effectiveness análisis. Aliment Pharmacol Ther 2000;14:1631-8.
123. Fendrick AM, Chernew ME, Hirth RA, Bloom BS. Alternative management strategies for patients with suspected peptic ulcer disease. Ann Intem Med 1995;123:260-8.
124. Graham DY, Hepps KS, Ramírez FC, Lew GM, Saeed ZA. Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease. Scand J Gastroenterol 1993;28:939-42.
125. Rokkas T, Karamaris A, Mavrogeorgis A, Rallis E, Giannikos N. Eradication of Helicobacter pylori reduces the possibility of rebleeding in peptic ulcer disease. Gastrointest Endosc 1995;41:1-4.
126. Macri G, Milani S, Surrenti E, Passaleva MT, Salvadori G, Surrenti C. Eradication of Helicobacter pylori reduces the rate of duodenal ulcer rebleeding: a long-term follow-up study. Am J Gastroenterol 1998;3:925-7.
127. Sung JJY, Leung WK, Suen R, Leung VKS, Chan FKL, Ling TKW, Lau JYW, et al. One-week antibiotics versus maintenance acid suppression therapy for Helicobacter pylori-associated peptic ulcer bleeding. Dig Dis Sci 1997;42:2524-8.
128. Pellicano R, Pierre S, Leone N, Repici A, De Angelis C, Rizzi R. The effect of the eradication of Helicobacter pylori infection on hemorrhage because of duodenal ulcer. J Clin Gastroenterol 2001;32:222-4.
129. Gisbert JP, González L, Calvet X, García N, López T, Roqué M, et al. Proton pump inhibitor, clarithromycin and amoxycillin or nitroimidazole: a meta-analysis of eradication of Helicobacter pylori. Aliment Pharmacol Ther 2000;14:1319-28.
130. Calvet X, Gené E, López T, Gisbert JP. What is the optimal length of proton pump inhibitor-based triple therapies for H. pylori? A cost-effectiveness analysis. Aliment Pharmacol Ther 2001;15:1067-76.
131. Vallvé M, Vergara M, Gisbert JP, Calvet X. Single versus double dose of a proton pump inhibitor in triple therapy for Helicobacter pylori eradication: a meta-analysis. Aliment Pharmacol Ther 2002;16:1149-56.
132. Graham DY, Osato MS, Hoffman J, Opekun AR, Anderson SY, Kwon DH, et al. Metronidazole containing quadruple therapy for infection with metronidazole resistant Helicobacter pylori: a prospective study.
133. Calvet X, García N, Gené E, Campo R, Brullet E, Sanfeliu I. Modified seven-day, quadruple therapy as a first line Helicobacter pylori treatment. Aliment Pharmacol Ther 2001;15:1061-5.
134. Calvet X, Ducons J, Guardiola J, Titó L, Andreu V, Bory F, Guirao R (Gresca). One-week triple versus quadruple therapy for Helicobacter pylori infection: a randomized trial. Aliment Pharmacol Ther 2002;16:1261-7.
135. Hopkins RJ, Girardi LS, Turney EA. Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review. Gastroenterology 1996;110:1244-52.
136. Lerang F, Moum B, Mowinckel P, Hang JB, Ragnhildstveit E, Berge T, et al. Accuracy of seven different test for the diagnosis of Helicobacter pylori infection and the impact of H2-receptor antagonist on test results. Scand J Gastroenterol 1998;33:364-9.
137. 14C-urea breath test. Am J Gastroenterol 1996;91:89-92.
138. 14C-urea breath test by a pH-dependant mechanism. Am J Gastroenterol 1997;92:446-50.
139. Yeomans ND, Tulassay Z, Juhasz L, Racz I, Howard JM, Van Rensburg CJ, et al (ASTRONAUT). A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. N Engl J Med 1998;338:719-26.
140. Hawkey CJ, Karrasch JA, Szczepanski L, Walker DG, Barkun A, Swannell AJ, et al (OMNIUM). Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. N Engl J Med 1998;338:727-34.
141. Leung WK, Sung JJY, Siu KLK, Chan FK, Ling TK, Cheng AF. False-negative biopsy urease test in bleeding ulcers caused by the buffering effects of blood. Am J Gastroenterol 1998;93:1914-8.
142. Lee JM, Breslin NP, Fallon C, O'Morain CA. Rapid urease tests lack sensitivity in Helicobacter pylori diagnosis when peptic ulcer disease presents with bleeding. Am J Gastroenterol 2000;95:1166:70.
143. Chan FK, Chung SC, Suen BY, Lee YT, Leung WK, Leung VK, et al. Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen. N Engl J Med 2001;344:967-73.
144. Chan FKL, To KF, Wu JCY, Yung MY, Leung WK, Kwok T, et al. Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial. Lancet 2002;359:9-13.
145. Gisbert JP, Calvet X, Gomollón F, Sáinz R. Tratamiento erradicador de Helicobacter pylori. Recomendaciones de la Conferencia Española de Consenso. Med Clin (Barc) 2000;114:185-95.
146. Bombardier C, Laine L, Reicin A, Shapiro D, Burgos-Vargas R, Davis B, et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med 2000;343:1520-8.
147. Hawkey CJ. Gastrointestinal safety of COX-2 specific inhibitors. Gastroenterol Clin North Am 2001;30:921-36.